Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Conduit Pharmaceuticals ( (CDT) ) has issued an announcement.
Conduit Pharmaceuticals Inc. has been notified by Nasdaq of its non-compliance with the listing rule due to its stock price falling below $1.00 per share for 30 consecutive business days, with the price dropping to $0.10 or less for ten consecutive trading days. In response, the company plans to request a hearing to prevent delisting and has approved a reverse stock split to regain compliance. The company’s annual meeting resulted in the election of directors, ratification of an accounting firm, and approval of the reverse stock split amendment.
More about Conduit Pharmaceuticals
YTD Price Performance: -98.57%
Average Trading Volume: 25,737,234
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.86M
See more data about CDT stock on TipRanks’ Stock Analysis page.
